PROSTAGLANDINA E2 PARA LA PREVENCION O EL TRATAMIENTO DE LINFOMAS LINFOBLASTICOS

Prostaglandin e2 for the prevention or treatment of lymphoblastic lymphomas. The present invention falls within the field of molecular biology and medicine. Specifically, it relates to the use of prostaglandin e2 (pge2) or any of its biologically active salts, derivatives or analogs, or any combinat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VILLA MORALES, MARIA, FRESNO, MANUEL, SANTOS HERNANDEZ, JAVIER, FERNANDEZ NAVARRO, PABLO, FERNANDEZ PIQUERAS, JOSE, GONZALEZ SANCHES, LAURA
Format:	Patent
Sprache:	spa
Schlagworte:	HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Prostaglandin e2 for the prevention or treatment of lymphoblastic lymphomas. The present invention falls within the field of molecular biology and medicine. Specifically, it relates to the use of prostaglandin e2 (pge2) or any of its biologically active salts, derivatives or analogs, or any combination thereof, for the manufacture of a medicament for the prevention or treatment of lymphoblastic lymphoma. (Machine-translation by Google Translate, not legally binding)